Meel R, Kulkarni S, Singh L, Chinnaswamy G, Radhakrishnan V, Madan R
Indian J Pediatr. 2024; 91(11):1166-1176.
PMID: 38609685
DOI: 10.1007/s12098-024-05095-0.
Yadav G, Singh A, Kushwaha R, Verma N, Srivastava R, Singh U
J Med Life. 2023; 16(8):1245-1250.
PMID: 38024824
PMC: 10652682.
DOI: 10.25122/jml-2023-0156.
Ghassemi F, Rahimi M, Riazi-Esfahani H, Khodabandeh A, Masoomian B, Taghizadeh S
Case Rep Ophthalmol. 2023; 14(1):340-347.
PMID: 37901645
PMC: 10601821.
DOI: 10.1159/000531527.
Jabir A, Zaheer H, Zaheer M, Zaheer E, Birdsong R
Cureus. 2022; 14(10):e30074.
PMID: 36381807
PMC: 9639857.
DOI: 10.7759/cureus.30074.
Li Z, Guo J, Xu X, Wei W, Xian J
Br J Radiol. 2021; 95(1130):20211027.
PMID: 34826253
PMC: 8822570.
DOI: 10.1259/bjr.20211027.
Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.
Borah N, Sradhanjali S, Barik M, Jha A, Tripathy D, Kaliki S
Invest Ophthalmol Vis Sci. 2021; 62(3):16.
PMID: 33704359
PMC: 7960835.
DOI: 10.1167/iovs.62.3.16.
Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis.
Cho S, Kim J, Baik S, Sunwoo L, Bae Y, Choi B
Neuroradiology. 2020; 63(4):499-509.
PMID: 32865636
DOI: 10.1007/s00234-020-02538-1.
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chevez-Barrios P, Eagle Jr R, Krailo M, Piao J, Albert D, Gao Y
J Clin Oncol. 2019; 37(31):2883-2891.
PMID: 31539297
PMC: 6823888.
DOI: 10.1200/JCO.18.01808.
Lurking below: massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma.
Kogachi K, Kim J, Green S, Jubran R, Berry J
Ophthalmic Genet. 2018; 39(5):653-657.
PMID: 30142285
PMC: 6613565.
DOI: 10.1080/13816810.2018.1513535.
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
Webb A, Gao B, Goldsmith Z, Irvine A, Saleh N, Lee R
BMC Cancer. 2017; 17(1):434.
PMID: 28633655
PMC: 5477686.
DOI: 10.1186/s12885-017-3418-y.
Diffuse Anterior Retinoblastoma with Sarcoidosis-Like Nodule.
Kitazawa K, Nagata K, Yamanaka Y, Kuwahara Y, Iehara T, Kinoshita S
Case Rep Ophthalmol. 2016; 6(3):443-7.
PMID: 26955346
PMC: 4777930.
DOI: 10.1159/000442744.
Risk definition and management strategies in retinoblastoma: current perspectives.
Ghassemi F, Khodabande A
Clin Ophthalmol. 2015; 9:985-94.
PMID: 26089630
PMC: 4467752.
DOI: 10.2147/OPTH.S59828.
High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.
Sirin S, Schlamann M, Metz K, Bornfeld N, Schweiger B, Holdt M
Neuroradiology. 2015; 57(8):805-14.
PMID: 26041632
DOI: 10.1007/s00234-015-1544-2.
MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.
Galluzzi P, Hadjistilianou T, Cerase A, Toti P, Leonini S, Bracco S
Neuroradiol J. 2015; 28(1):53-61.
PMID: 25924174
PMC: 4757124.
DOI: 10.15274/NRJ-2014-10103.
Retinoblastoma: achieving new standards with methods of chemotherapy.
Kaliki S, Shields C
Indian J Ophthalmol. 2015; 63(2):103-9.
PMID: 25827539
PMC: 4399117.
DOI: 10.4103/0301-4738.154369.
Histopathologic grading of anaplasia in retinoblastoma.
Mendoza P, Specht C, Hubbard G, Wells J, Lynn M, Zhang Q
Am J Ophthalmol. 2014; 159(4):764-76.
PMID: 25528954
PMC: 4361305.
DOI: 10.1016/j.ajo.2014.12.014.
Innovative ophthalmology.
Natarajan S
Indian J Ophthalmol. 2014; 62(11):1043-1044.
PMID: 25494243
PMC: 4290191.
DOI: 10.4103/0301-4738.146706.
Characteristics of Germline and Non-germline Retinoblastomas.
Ghassemi F, Chams H, Sabour S, Karkhaneh R, Farzbod F, Khodaparast M
J Ophthalmic Vis Res. 2014; 9(2):188-94.
PMID: 25279120
PMC: 4181201.
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.
Grossniklaus H
Am J Ophthalmol. 2014; 158(5):875-91.
PMID: 25065496
PMC: 4250440.
DOI: 10.1016/j.ajo.2014.07.025.
Establishment of the relationship between tumor size and range of histological involvement to evaluate the rationality of current retinoblastoma management.
Yan J, Zhang H, Li Y
PLoS One. 2013; 8(11):e80484.
PMID: 24312226
PMC: 3842917.
DOI: 10.1371/journal.pone.0080484.